Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats

Introduction Methotrexate (MTX) causes hepatotoxicity by producing oxidative stress. Benfotiamine and irisin have protective effects against oxidative stress. The aim of this study was to investigate the changes in irisin activity in the liver as a result of toxicity produced by MTX and the protecti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mehmet Ali Erdogan, Alper Yalcin
Formato: article
Lenguaje:EN
Publicado: Termedia Publishing House 2019
Materias:
R
Acceso en línea:https://doaj.org/article/5da203d1c88d4527ad0775cdb99de6c9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5da203d1c88d4527ad0775cdb99de6c9
record_format dspace
spelling oai:doaj.org-article:5da203d1c88d4527ad0775cdb99de6c92021-12-02T18:39:22ZProtective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats1734-19221896-915110.5114/aoms.2018.80002https://doaj.org/article/5da203d1c88d4527ad0775cdb99de6c92019-12-01T00:00:00Zhttps://www.archivesofmedicalscience.com/Protective-effects-of-benfotiamine-on-irisin-activity-in-methotrexate-induced-liver,99247,0,2.htmlhttps://doaj.org/toc/1734-1922https://doaj.org/toc/1896-9151Introduction Methotrexate (MTX) causes hepatotoxicity by producing oxidative stress. Benfotiamine and irisin have protective effects against oxidative stress. The aim of this study was to investigate the changes in irisin activity in the liver as a result of toxicity produced by MTX and the protective role of benfotiamine in the hepatotoxicity. Material and methods Rats were divided into 4 groups as follows: control, benfotiamine (50 mg/kg, oral gavage (o.g.), for 14 days), MTX (MTX 20 mg/kg intraperitoneally (i.p.) on day 1), MTX + benfotiamine (MTX 20 mg/kg (i.p.) on day 1, then 50 mg/kg (o.g.) benfotiamine for 14 days). Liver tissue was used to examine histopathological and immunohistochemical changes. Serum was used to look for oxidative stress markers (total antioxidant status (TAS) and total oxidant status (TOS)). Results Administration of MTX caused a significant TOS increase and TAS decrease in the serum as compared to the control group. Immunohistochemically, irisin was significantly increased in immunoreactivity in the MTX group as compared to the control group (p < 0.05). Significant histopathological improvement and decrease in serum TOS levels were observed in the MTX + benfotiamine group compared to the MTX group (p 0.05). Conclusions Our results showed that MTX caused an increase in the activity of irisin after producing toxicity in the liver. In addition, we found that benfotiamine was effective in preventing damage caused by MTX in the liver.Mehmet Ali ErdoganAlper YalcinTermedia Publishing Housearticleirisinliver toxicitybenfotiamineoxidative stressratsMedicineRENArchives of Medical Science, Vol 16, Iss 1, Pp 205-211 (2019)
institution DOAJ
collection DOAJ
language EN
topic irisin
liver toxicity
benfotiamine
oxidative stress
rats
Medicine
R
spellingShingle irisin
liver toxicity
benfotiamine
oxidative stress
rats
Medicine
R
Mehmet Ali Erdogan
Alper Yalcin
Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
description Introduction Methotrexate (MTX) causes hepatotoxicity by producing oxidative stress. Benfotiamine and irisin have protective effects against oxidative stress. The aim of this study was to investigate the changes in irisin activity in the liver as a result of toxicity produced by MTX and the protective role of benfotiamine in the hepatotoxicity. Material and methods Rats were divided into 4 groups as follows: control, benfotiamine (50 mg/kg, oral gavage (o.g.), for 14 days), MTX (MTX 20 mg/kg intraperitoneally (i.p.) on day 1), MTX + benfotiamine (MTX 20 mg/kg (i.p.) on day 1, then 50 mg/kg (o.g.) benfotiamine for 14 days). Liver tissue was used to examine histopathological and immunohistochemical changes. Serum was used to look for oxidative stress markers (total antioxidant status (TAS) and total oxidant status (TOS)). Results Administration of MTX caused a significant TOS increase and TAS decrease in the serum as compared to the control group. Immunohistochemically, irisin was significantly increased in immunoreactivity in the MTX group as compared to the control group (p < 0.05). Significant histopathological improvement and decrease in serum TOS levels were observed in the MTX + benfotiamine group compared to the MTX group (p 0.05). Conclusions Our results showed that MTX caused an increase in the activity of irisin after producing toxicity in the liver. In addition, we found that benfotiamine was effective in preventing damage caused by MTX in the liver.
format article
author Mehmet Ali Erdogan
Alper Yalcin
author_facet Mehmet Ali Erdogan
Alper Yalcin
author_sort Mehmet Ali Erdogan
title Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
title_short Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
title_full Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
title_fullStr Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
title_full_unstemmed Protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
title_sort protective effects of benfotiamine on irisin activity in methotrexate-induced liver injury in rats
publisher Termedia Publishing House
publishDate 2019
url https://doaj.org/article/5da203d1c88d4527ad0775cdb99de6c9
work_keys_str_mv AT mehmetalierdogan protectiveeffectsofbenfotiamineonirisinactivityinmethotrexateinducedliverinjuryinrats
AT alperyalcin protectiveeffectsofbenfotiamineonirisinactivityinmethotrexateinducedliverinjuryinrats
_version_ 1718377740688687104